APO RESEARCH · REPORT
Influenza Diagnostics
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
Product & engineering
Understand the product.
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
Selected research
Industry Research
Influenza Diagnostics Industry Research Report 2026
Market perspective
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.
Read the full market overview
Report Scope
This report quantifies the global Influenza Diagnostics market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Influenza Diagnostics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Influenza Diagnostics Market by Company
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
Influenza Diagnostics Segment by Type
RIDT
RT-PCR
Cell Culture
Others
Influenza Diagnostics Segment by Application
Hospitals
POCT
Others
Influenza Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Influenza Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Influenza Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- RIDT
- RT-PCR
- Cell Culture
- Others
Applications
- Hospitals
- POCT
- Others
Companies covered
- BD
- Abbott (Include Alere)
- Roche
- SIEMENS
- Analytik Jena
- Quidel
- Thermo Fisher
- Meridian Bioscience
- BioMerieux
- Sekisui Diagnostics
- Response Biomedical
- SA Scientific
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Influenza Diagnostics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 RIDT
- 2.2.3 RT-PCR
- 2.2.4 Cell Culture
- 2.2.5 Others
- 2.3 Influenza Diagnostics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 POCT
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Influenza Diagnostics Breakdown Data by Type
- 3.1 Global Influenza Diagnostics Historic Market Size by Type (2021-2026)
- 3.2 Global Influenza Diagnostics Forecasted Market Size by Type (2027-2032)
4 Influenza Diagnostics Breakdown Data by Application
- 4.1 Global Influenza Diagnostics Historic Market Size by Application (2021-2026)
- 4.2 Global Influenza Diagnostics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Influenza Diagnostics Market Perspective (2021-2032)
- 5.2 Global Influenza Diagnostics Growth Trends by Region
- 5.2.1 Global Influenza Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Influenza Diagnostics Historic Market Size by Region (2021-2026)
- 5.2.3 Influenza Diagnostics Forecasted Market Size by Region (2027-2032)
- 5.3 Influenza Diagnostics Market Dynamics
- 5.3.1 Influenza Diagnostics Industry Trends
- 5.3.2 Influenza Diagnostics Market Drivers
- 5.3.3 Influenza Diagnostics Market Challenges
- 5.3.4 Influenza Diagnostics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Influenza Diagnostics Players by Revenue
- 6.1.1 Global Top Influenza Diagnostics Players by Revenue (2021-2026)
- 6.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2021-2026)
- 6.2 Global Influenza Diagnostics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Influenza Diagnostics Head Office and Area Served
- 6.4 Global Influenza Diagnostics Players, Product Type & Application
- 6.5 Global Influenza Diagnostics Manufacturers Established Date
- 6.6 Global Influenza Diagnostics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Influenza Diagnostics Market Size (2021-2032)
- 7.2 North America Influenza Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Influenza Diagnostics Market Size by Country (2021-2026)
- 7.4 North America Influenza Diagnostics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Influenza Diagnostics Market Size (2021-2032)
- 8.2 Europe Influenza Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Influenza Diagnostics Market Size by Country (2021-2026)
- 8.4 Europe Influenza Diagnostics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Influenza Diagnostics Market Size (2021-2032)
- 9.2 Asia-Pacific Influenza Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Influenza Diagnostics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Influenza Diagnostics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Influenza Diagnostics Market Size (2021-2032)
- 10.2 South America Influenza Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Influenza Diagnostics Market Size by Country (2021-2026)
- 10.4 South America Influenza Diagnostics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Influenza Diagnostics Market Size (2021-2032)
- 11.2 Middle East & Africa Influenza Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Influenza Diagnostics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Influenza Diagnostics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 BD
- 12.1.1 BD Company Information
- 12.1.2 BD Business Overview
- 12.1.3 BD Revenue in Influenza Diagnostics Business (2021-2026)
- 12.1.4 BD Influenza Diagnostics Product Portfolio
- 12.1.5 BD Recent Developments
- 12.2 Abbott (Include Alere)
- 12.2.1 Abbott (Include Alere) Company Information
- 12.2.2 Abbott (Include Alere) Business Overview
- 12.2.3 Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2021-2026)
- 12.2.4 Abbott (Include Alere) Influenza Diagnostics Product Portfolio
- 12.2.5 Abbott (Include Alere) Recent Developments
- 12.3 Roche
- 12.3.1 Roche Company Information
- 12.3.2 Roche Business Overview
- 12.3.3 Roche Revenue in Influenza Diagnostics Business (2021-2026)
- 12.3.4 Roche Influenza Diagnostics Product Portfolio
- 12.3.5 Roche Recent Developments
- 12.4 SIEMENS
- 12.4.1 SIEMENS Company Information
- 12.4.2 SIEMENS Business Overview
- 12.4.3 SIEMENS Revenue in Influenza Diagnostics Business (2021-2026)
- 12.4.4 SIEMENS Influenza Diagnostics Product Portfolio
- 12.4.5 SIEMENS Recent Developments
- 12.5 Analytik Jena
- 12.5.1 Analytik Jena Company Information
- 12.5.2 Analytik Jena Business Overview
- 12.5.3 Analytik Jena Revenue in Influenza Diagnostics Business (2021-2026)
- 12.5.4 Analytik Jena Influenza Diagnostics Product Portfolio
- 12.5.5 Analytik Jena Recent Developments
- 12.6 Quidel
- 12.6.1 Quidel Company Information
- 12.6.2 Quidel Business Overview
- 12.6.3 Quidel Revenue in Influenza Diagnostics Business (2021-2026)
- 12.6.4 Quidel Influenza Diagnostics Product Portfolio
- 12.6.5 Quidel Recent Developments
- 12.7 Thermo Fisher
- 12.7.1 Thermo Fisher Company Information
- 12.7.2 Thermo Fisher Business Overview
- 12.7.3 Thermo Fisher Revenue in Influenza Diagnostics Business (2021-2026)
- 12.7.4 Thermo Fisher Influenza Diagnostics Product Portfolio
- 12.7.5 Thermo Fisher Recent Developments
- 12.8 Meridian Bioscience
- 12.8.1 Meridian Bioscience Company Information
- 12.8.2 Meridian Bioscience Business Overview
- 12.8.3 Meridian Bioscience Revenue in Influenza Diagnostics Business (2021-2026)
- 12.8.4 Meridian Bioscience Influenza Diagnostics Product Portfolio
- 12.8.5 Meridian Bioscience Recent Developments
- 12.9 BioMerieux
- 12.9.1 BioMerieux Company Information
- 12.9.2 BioMerieux Business Overview
- 12.9.3 BioMerieux Revenue in Influenza Diagnostics Business (2021-2026)
- 12.9.4 BioMerieux Influenza Diagnostics Product Portfolio
- 12.9.5 BioMerieux Recent Developments
- 12.10 Sekisui Diagnostics
- 12.10.1 Sekisui Diagnostics Company Information
- 12.10.2 Sekisui Diagnostics Business Overview
- 12.10.3 Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2021-2026)
- 12.10.4 Sekisui Diagnostics Influenza Diagnostics Product Portfolio
- 12.10.5 Sekisui Diagnostics Recent Developments
- 12.11 Response Biomedical
- 12.11.1 Response Biomedical Company Information
- 12.11.2 Response Biomedical Business Overview
- 12.11.3 Response Biomedical Revenue in Influenza Diagnostics Business (2021-2026)
- 12.11.4 Response Biomedical Influenza Diagnostics Product Portfolio
- 12.11.5 Response Biomedical Recent Developments
- 12.12 SA Scientific
- 12.12.1 SA Scientific Company Information
- 12.12.2 SA Scientific Business Overview
- 12.12.3 SA Scientific Revenue in Influenza Diagnostics Business (2021-2026)
- 12.12.4 SA Scientific Influenza Diagnostics Product Portfolio
- 12.12.5 SA Scientific Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst